1. Home
  2. REVB vs KXIN Comparison

REVB vs KXIN Comparison

Compare REVB & KXIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Revelation Biosciences Inc.

REVB

Revelation Biosciences Inc.

N/A

Current Price

$3.74

Market Cap

1.9M

Sector

Health Care

ML Signal

N/A

KXIN

Kaixin Auto Holdings

N/A

Current Price

$2.54

Market Cap

1.7M

ML Signal

N/A

Company Overview

Basic Information
Metric
REVB
KXIN
Founded
2020
2015
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Retail-Auto Dealers and Gas Stations
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.9M
1.7M
IPO Year
2020
2017

Fundamental Metrics

Financial Performance
Metric
REVB
KXIN
Price
$3.74
$2.54
Analyst Decision
Analyst Count
0
0
Target Price
★ $124.25
N/A
AVG Volume (30 Days)
64.7K
★ 680.3K
Earning Date
11-05-2026
11-26-2019
Dividend Yield
N/A
N/A
EPS Growth
★ 72.68
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.44
$0.11
52 Week High
$4.75
$22.00

Technical Indicators

Market Signals
Indicator
REVB
KXIN
Relative Strength Index (RSI) 65.12 72.98
Support Level $0.97 $0.42
Resistance Level $4.06 $2.81
Average True Range (ATR) 0.36 0.17
MACD 0.01 0.10
Stochastic Oscillator 27.56 95.19

Price Performance

Historical Comparison
REVB
KXIN

About REVB Revelation Biosciences Inc.

Revelation Biosciences Inc is a clinical-stage life science company focused on rebalancing inflammation to optimize health using its proprietary formulation, Gemini. The company is developing a pipeline of potential products based on Gemini, which is its proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD), a synthetic version of monophosphoryl lipid A (MPLA). PHAD is a small fragment of lipopolysaccharide (LPS) that stimulates TLR4 and leads to controlled production of multiple cytokines and chemokines that modulate the innate and adaptive immune response. The company operates through one reportable segment focused on the prevention and treatment of disease by developing and commercializing therapeutics that modulate the innate immune system.

About KXIN Kaixin Auto Holdings

Kaixin Holdings is an auto dealership company mainly engaged in the sale of domestic and imported automobiles in China. The company provides new and used car buyers in China with access to a wide selection of used vehicles across its network of dealerships, with a focus on premium brands such as Audi, BMW, Mercedes-Benz, Land Rover, and Porsche. The company generates revenue from automobile sales and related services.

Share on Social Networks: